Tasso
3 Case Studies
A Tasso Case Study
a clinical-stage pharmaceutical company faced a significant challenge in its Phase 2 study, as it needed to collect pharmacokinetic (PK) samples from patients dosing for an unpredictable, acute onset condition. Traditional clinic-based sampling was not feasible, and existing remote methods had poor compliance rates. The company partnered with Tasso to implement a patient-centric, remote blood collection solution.
Tasso provided a tailored solution using its virtually painless blood collection device and dried blood spot (DBS) samples. The program included custom sampling kits and training to empower patients and sites. This approach achieved exceptional compliance, with 99.8% of patients attempting the critical 2-hour sample and compliance rates above 98% at all three timepoints. The success of Tasso's solution enabled robust exposure-response analysis without relying on clinic visits.
Sponsor